A Study Of Ursolic Acid For Primary Sclerosing Cholangitis
Status:
Withdrawn
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
This is an open-label, active treatment trial to determine the pharmacokinetics of orally
administered ursolic acid and to assess the potential efficacy and safety of ursolic acid in
subjects with primary sclerosing cholangitis (PSC).